Development and validation of a clinically applicable score to classify cachexia stages in advanced cancer patients

Abstract Background Cachexia is a multifactorial syndrome that is highly prevalent in advanced cancer patients and leads to progressive functional impairments. The classification of cachexia stages is essential for diagnosing and treating cachexia. However, there is a lack of simple tools with good...

Full description

Bibliographic Details
Published in:	Journal of Cachexia, Sarcopenia and Muscle
Main Authors:	Ting Zhou, Bangyan Wang, Huiquan Liu, Kaixiang Yang, Sudip Thapa, Haowen Zhang, Lu Li, Shiying Yu
Format:	Article
Language:	English
Published:	Wiley 2018-04-01
Subjects:	Cancer Cachexia Classification Quality of life Survival
Online Access:	https://doi.org/10.1002/jcsm.12275

Similar Items

Cachexia index as a biomarker for cancer cachexia and quality of life in patients with gastric cancer
by: Yan Huang, et al.
Published: (2025-08-01)

Validity of the diagnostic criteria from the Asian Working Group for Cachexia in advanced cancer
by: Tatsuma Sakaguchi, et al.
Published: (2024-02-01)

CONUT score as a predictor for anamorelin efficacy in patients with cancer cachexia receiving chemotherapy
by: Hironori Fujii, et al.
Published: (2024-07-01)

Oncological and Survival Endpoints in Cancer Cachexia Clinical Trials: Systematic Review 6 of the Cachexia Endpoints Series
by: Olav Dajani, et al.
Published: (2025-04-01)

The atypical β‐blocker S‐oxprenolol reduces cachexia and improves survival in a rat cancer cachexia model
by: Luping Yuan, et al.
Published: (2023-02-01)

Cancer Cachexia: Innovations in Pharmacotherapy for Terminal-Stage Patients - Review of the latest reports
by: Kinga Witowska, et al.
Published: (2025-01-01)

Cancer Cachexia
by: Tanadech Dechaphunkul
Published: (2011-10-01)

Influence of cachexia on immunotherapy efficacy and prognosis for malignant tumors of the digestive system
by: Zhirui Tao, et al.
Published: (2024-05-01)

Cachexia, fatigue, and quality of life in patients undergoing hemodialysis
by: Takahiro Yajima
Published: (2025-06-01)

Clinical validation of AWGC-defined cachexia in gastric cancer patients: impact on body composition and quality of life
by: Yan Huang, et al.
Published: (2025-10-01)

Comment on ‘Oncological and Survival Endpoints in Cancer Cachexia Clinical Trials: Systematic Review 6 of the Cachexia Endpoint Series’ by Dajani et al.—The Authors' Reply
by: Jann Arends, et al.
Published: (2025-10-01)

Hand grip strength‐based cachexia index as a predictor of cancer cachexia and prognosis in patients with cancer
by: Hailun Xie, et al.
Published: (2023-02-01)

A Comprehensive Analysis of the Association Between the EORTC QLQ‐C30 Questionnaire and Cachexia in Patients With Gastric Cancer
by: Xi Zhang, et al.
Published: (2025-06-01)

Quality of life endpoints in cancer cachexia clinical trials: Systematic review 3 of the cachexia endpoints series
by: Marianne J. Hjermstad, et al.
Published: (2024-06-01)

Body weight and composition endpoints in cancer cachexia clinical trials: Systematic Review 4 of the cachexia endpoints series
by: Leo R. Brown, et al.
Published: (2024-06-01)

Pathogenetic aspects of cachexia
by: Irina S. Klochkova, et al.
Published: (2020-06-01)

Cancer anorexia‐cachexia syndrome is characterized by more than one inflammatory pathway
by: Bruno Gagnon, et al.
Published: (2024-06-01)

Cancer cachexia
by: Kunze Philipp, et al.
Published: (2003-11-01)

Cachexia and advanced dementia
by: Cecilia Minaglia, et al.
Published: (2019-04-01)

Prevalence of rheumatoid cachexia in rheumatoid arthritis: a systematic review and meta‐analysis
by: Rafaela C.E. Santo, et al.
Published: (2018-10-01)

The impact of cachexia on dietary intakes, symptoms, and quality of life in advanced cancer
by: Koji Amano, et al.
Published: (2022-07-01)

Relationship of Cachexia with Self-Care Agency and Quality of Life in Cancer Patients: The Case of Turkey
by: Hatice Demirag, et al.
Published: (2021-01-01)

Geriatric Nutrition Risk Index: Prognostic factor related to inflammation in elderly patients with cancer cachexia
by: Guo‐Tian Ruan, et al.
Published: (2021-12-01)

AWGC2023 cachexia consensus as a valuable tool for predicting prognosis and burden in Chinese patients with cancer
by: Hailun Xie, et al.
Published: (2024-10-01)

Recent developments in the field of cachexia, sarcopenia, and muscle wasting: highlights from the 11th Cachexia Conference
by: Nicole Ebner, et al.
Published: (2019-02-01)

Recent developments in the field of cachexia, sarcopenia, and muscle wasting: highlights from the 12th Cachexia Conference
by: Nicole Ebner, et al.
Published: (2020-02-01)

The pathophysiology of cancer‐mediated cardiac cachexia and novel treatment strategies: A narrative review
by: Louisa Tichy, et al.
Published: (2023-09-01)

Multicomponent Interventions for Adults With Cancer Cachexia: A Systematic Review
by: Megan Bowers, et al.
Published: (2025-04-01)

NCR as a biomarker for nutritional status and inflammation in predicting outcomes in patients with cancer cachexia: a prospective, multicenter study
by: Xiangrui Li, et al.
Published: (2025-03-01)

Development and validation of a cancer cachexia risk score for digestive tract cancer patients before abdominal surgery
by: Shanjun Tan, et al.
Published: (2023-04-01)

Cannabinoid interventions for improving cachexia outcomes in cancer: a systematic review and meta‐analysis
by: Lucile Simon, et al.
Published: (2022-02-01)

Adipose Tissue and Cancer Cachexia: What Nurses Need to Know
by: Susan Mcclement
Published: (2021-01-01)

Biomarker endpoints in cancer cachexia clinical trials: Systematic Review 5 of the cachexia endpoint series
by: Michael S. Yule, et al.
Published: (2024-06-01)

Natural ghrelin in advanced cancer patients with cachexia, a case series
by: David Blum, et al.
Published: (2021-04-01)

Furnishing the cachexia landscape: A year of research in JCSM
by: Ann‐Kathrin Fröhlich, et al.
Published: (2022-12-01)

Inpatient Outcomes of Cirrhosis-related Cachexia in the United States
by: Mohammad Alabbas, et al.
Published: (2024-01-01)

The differential effects of sarcopenia and cachexia on overall survival for pancreatic ductal adenocarcinoma patients following pancreatectomy: A retrospective study based on a large population
by: Xiao‐ding Shen, et al.
Published: (2023-05-01)

Are measures and related symptoms of cachexia recorded as outcomes in gastrointestinal cancer chemotherapy clinical trials?
by: Ross Valaire, et al.
Published: (2024-06-01)

Immunoregulation in cancer-associated cachexia
by: Qi Wu, et al.
Published: (2024-04-01)

Cachexia with ascites: a diagnostic dilemma—a case report
by: Harvinder Kaur Palaha, et al.
Published: (2025-09-01)